Suchergebnisse - "Pfirrmann, M"

PubPharm (61)

1

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation : the RuxCoFlam trial

enthalten in: Leukemia | 2023

von Hammersen, J. | Birndt, S. | Döhner, K. | +15

2

Regional deep hyperthermia : quantitative evaluation of predicted and direct measured temperature distributions in patients with high-risk extremity soft-tissue sarcoma

enthalten in: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group | 2019

von Aklan, B. | Zilles, B. | Paprottka, P. | +5

3

Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2018

von Rupprecht, T. | Manz, K. | Fingerle, V. | +4

4

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML

enthalten in: Leukemia | 2018

von Schütz, C. | Inselmann, S. | Saussele, S. | +24

ErratumFor: Leukemia. 2017 Apr;31(4):829-836. - PMID 28074067

5

Assessment of imatinib as first-line treatment of chronic myeloid leukemia : 10-year survival results of the randomized CML study IV and impact of non-CML determinants

enthalten in: Leukemia | 2017

von Hehlmann, R. | Lauseker, M. | Saußele, S. | +67

CommentIn: Haematologica. 2019 May;104(5):862-864. - PMID 31040230

6

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML

enthalten in: Leukemia | 2017

von Schütz, C. | Inselmann, S. | Saussele, S. | +24

ErratumIn: Leukemia. 2018 Jan 30;:. - PMID 29381150

7

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML

enthalten in: Leukemia | 2017

von Schütz, C. | Inselmann, S. | Sausslele, S. | +24

8

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML

enthalten in: Leukemia | 2017

von Schütz, C. | Inselmann, S. | Sausslele, S. | +24

9

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment : long-term observation in CML Study IV

enthalten in: Leukemia | 2016

von Miranda, M. | Lauseker, M. | Kraus, M. | +26

10

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia : a randomized comparison of stem cell transplantation with drug treatment

enthalten in: Leukemia | 2016

von Gratwohl, A. | Pfirrmann, M. | Zander, A. | +57

1
2
3
4
5
6
7
Nächster »
[7]